Claire H. Li
Merck & Co., Inc., Rahway, NJ, USA (United States) · 12 works · 578 citations · h-index 8
Top works
- Systematic evaluation of pembrolizumab dosing in patients with advanced non-small-cell lung cancer
- Evaluation of dosing strategy for pembrolizumab for oncology indications
- Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies
- Time dependent pharmacokinetics of pembrolizumab in patients with solid tumor and its correlation with best overall response
- Model-Based Characterization of the Pharmacokinetics of Pembrolizumab: A Humanized Anti-PD-1 Monoclonal Antibody in Advanced Solid Tumors
- Current treatment landscape for patients with locally recurrent inoperable or metastatic triple-negative breast cancer: a systematic literature review
- Pharmacogenomics of Gemcitabine Metabolism: Functional Analysis of Genetic Variants in Cytidine Deaminase and Deoxycytidine Kinase
- Population Pharmacokinetic Modeling of Ziprasidone in Patients With Schizophrenia From the CATIE Study
- CYP3A5 genotype and its impact on vincristine pharmacokinetics and development of neuropathy in Kenyan children with cancer
- Expression of VEGF Gene Isoforms in a Rat Segmental Bone Defect Model Treated With EPCs
- Incidence, mitigation, and management of neurologic adverse events in patients with multiple myeloma (MM) treated with ciltacabtagene autoleucel (cilta-cel) in CARTITUDE-2.
- Genetic Variants Associated With Vincristine‐Induced Peripheral Neuropathy in Two Populations of Children With Acute Lymphoblastic Leukemia
- Comparative Effects of CT Imaging Measurement on RECIST End Points and Tumor Growth Kinetics Modeling
- Population Pharmacokinetic Modeling of Sertraline Treatment in Patients With Alzheimer Disease: The DIADS‐2 Study
- Population‐based cellular kinetic characterization of ciltacabtagene autoleucel in subjects with relapsed or refractory multiple myeloma
- Prediction of brain clozapine and norclozapine concentrations in humans from a scaled pharmacokinetic model for rat brain and plasma pharmacokinetics
- Clinical trial simulation to evaluate population pharmacokinetics and food effect: Capturing abiraterone and nilotinib exposures
- CYP3A5 genotype and its impact on vincristine pharmacokinetics and development of neuropathy in Kenyan children with cancer
- Effect of Human Vascular Endothelial Growth Factor Gene Transfer on Endogenous Vascular Endothelial Growth Factor mRNA Expression in a Rat Fibroblast and Osteoblast Culture Model
- Experimental Medicine Study to Measure Immune Checkpoint Receptors PD‐1 and GITR Turnover Rates In Vivo in Humans